Clinical Trials Directory

Trials / Completed

CompletedNCT04593277

Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study

INSPIRE-AYA: A Multicenter Interactive Survivorship Program to Improve Healthcare Resources for Adolescent and Young Adult (AYA) Cancer Survivors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
549 (actual)
Sponsor
Fred Hutchinson Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial studies how well an interactive survivorship program works in improving healthcare resources in adolescent and young adult cancer survivors. By improving access to survivorship resources, health literacy, self-management skills, and support, an interactive survivorship program may help to improve adherence to adolescent and young adult healthcare guidelines and reduce cancer-related distress.

Detailed description

OUTLINE: Patients who have one or more elevated distress or low cardiometabolic or cancer health care adherence are randomized to Arm I or II. ARM I (INTERVENTION): Patients receive a personalized Survivorship Care Plan (SCP) and use the Interactive Survivorship Program to Improve Healthcare Resources (INSPIRE) mobile application. Patients may receive telehealth stepped care after 1 month. ARM II (CONTROL): Patients receive access to a study-specific control website that has annotated links to existing resources for adolescent and young adult (AYA) survivors. After 12 months, patients receive a personalized SCP and have access to the digital INSPIRE intervention program without telehealth calls.

Conditions

Interventions

TypeNameDescription
OTHERInternet Mobile TechnologyUse INSPIRE mobile application
OTHERInternet-Based InterventionAccess to a study-specific control website
OTHERQuestionnaire AdministrationAncillary studies
PROCEDURESupportive CareReceive telehealth stepped care
OTHERInformational InterventionReceive printed SCP materials

Timeline

Start date
2022-10-23
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2020-10-19
Last updated
2026-01-23

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04593277. Inclusion in this directory is not an endorsement.